Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067
Shen Shen(First Affiliated Hospital of Zhengzhou University), Zhenfeng Duan(Harvard University Press)
Cited by 24
Related Papers
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
|Oncotarget|2017|208
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
|BMC Cancer|2009|161
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
|Scientific Reports|2015|156